- Home
- RAVE vs TLPH Comparison
RAVE vs TLPH Comparison
Compare RAVE & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAVE | TLPH |
|---|---|---|
| Founded | 1958 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.8M | 37.9M |
| IPO Year | 1995 | 2010 |
Fundamental Metrics
Financial Performance| Metric | RAVE | TLPH |
|---|---|---|
| Price | $2.97 | $0.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 25.6K | ★ 231.4K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.76 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $15,120,000.00 | $2,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $33.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.01 | $0.38 |
| 52 Week High | $3.75 | $1.57 |
Technical Indicators
Market Signals| Indicator | RAVE | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 38.54 | 51.26 |
| Support Level | $2.73 | $0.86 |
| Resistance Level | $3.21 | $1.05 |
| Average True Range (ATR) | 0.17 | 0.06 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 11.27 | 64.89 |
Price Performance
Historical ComparisonAbout RAVE Rave Restaurant Group Inc.
Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.